Hedge Fund Stock Picks & Ticker Coverage
Institutional ticker directory tracking stock mentions, long/short ideas, and high-conviction pitches extracted from quarterly hedge fund letters.
| Ticker | Company | Sector | Industry | Pitches | Stance |
|---|---|---|---|---|---|
Institutional ticker directory tracking stock mentions, long/short ideas, and high-conviction pitches extracted from quarterly hedge fund letters.
| Ticker | Company | Sector | Industry | Pitches | Stance |
|---|---|---|---|---|---|
| Fund / Manager | Thesis Excerpt | Stance | Period / Date | Action |
|---|---|---|---|---|
Rozendal Global Fund Wilhelm Hertzog, Paul Whitburn | “The Hedge Fund's investment in leading South African private school business Curro bears an uncanny resemblance to the Global Fund's investment in private hospital company Mediclinic. By mid-2023, the market was thoroughly despondent about Curro's prospects. Our view of Curro was somewhere between the wild enthusiasm of the market in the mid-2010's, and the dire disdain on display in the early 2020's. We proceeded to allocate capital to Curro shares, and for the next two years, Curro was a 2% - 3% position in the Hedge Fund. With the release of the (weak) half year results in August 2025, the company announced that the Jannie Mouton Foundation was making a bid to acquire 100% of Curro. Up to that point, the Hedge Fund had earned an internal rate of return of about 22% on its investment in Curro. We converted the Hedge Fund's Curro shares to swaps, shorted the requisite Capitec and PSG Financial Services shares, and waited for the transaction to close. The internal rate of return the Hedge Fund earned on this merger arbitrage investment was a most satisfactory 24%.” | NEUTRAL | Q2 2026 Aug 3, 2026 | View Pitch |
Each excerpt above is the manager's commentary on this ticker specifically. The full letter has the rest of their portfolio thinking, risk discussion, and broader institutional context.